Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies

Published:2009 Issue:5 Volume:32 Page:3-3
ISSN:1423-0240
Container-title:Onkologie
language:en
Short-container-title:Onkologie

Author:

Dian Darius,Janni Wolfgang,Kuhn Christina,Mayr Doris,Karsten Uwe,Mylonas Ioannis,Friese Klaus,Jeschke Udo

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology,General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody;Antibodies;2023-07-13

2. Mucin-Type O-GalNAc Glycosylation in Health and Disease;The Role of Glycosylation in Health and Disease;2021

3. Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer;International Journal of Molecular Sciences;2019-01-12

4. An overview of prostate diseases and their characteristics specific to Asian men;Asian Journal of Andrology;2012-02-06

5. Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8);Glycoconjugate Journal;2010-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP